Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Preferred Stock Liabilities (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Preferred Stock Liabilities for 5 consecutive years, with $10.5 million as the latest value for Q1 2020.

  • Quarterly Preferred Stock Liabilities changed 0.0% to $10.5 million in Q1 2020 from the year-ago period, while the trailing twelve-month figure was $10.5 million through Mar 2020, changed 0.0% year-over-year, with the annual reading at $10.5 million for FY2019, 85.81% up from the prior year.
  • Preferred Stock Liabilities for Q1 2020 was $10.5 million at Forte Biosciences, roughly flat from $10.5 million in the prior quarter.
  • The five-year high for Preferred Stock Liabilities was $131.4 million in Q4 2016, with the low at $67000.0 in Q1 2017.
  • Average Preferred Stock Liabilities over 5 years is $23.7 million, with a median of $10.5 million recorded in 2019.
  • The sharpest move saw Preferred Stock Liabilities soared 85.81% in 2019, then changed 0.0% in 2020.
  • Over 5 years, Preferred Stock Liabilities stood at $131.4 million in 2016, then crashed by 99.95% to $67000.0 in 2017, then soared by 8346.27% to $5.7 million in 2018, then skyrocketed by 85.81% to $10.5 million in 2019, then changed by 0.0% to $10.5 million in 2020.
  • According to Business Quant data, Preferred Stock Liabilities over the past three periods came in at $10.5 million, $10.5 million, and $10.5 million for Q1 2020, Q4 2019, and Q3 2019 respectively.